Who Owns Acurx Pharmaceuticals Stock?
NASDAQ: ACXPHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 3.65%
- Held by insiders
- 2.31%
- Institutional holders
- 20
- Institutions 3.6%
- Insiders 2.3%
- Public and other 94.0%
Who owns Acurx Pharmaceuticals stock?
Institutional investors own about 3.6% of Acurx Pharmaceuticals's shares, spread across 20 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 2.31% of ACXP.
The largest institutional holders are Vanguard Capital Management LLC (0.56%), Geode Capital Management, LLC (0.48%) and Vanguard Fiduciary Trust Co (0.29%). Together, the top 10 institutions control 2.1% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their ACXP positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ACXP
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 31.10K | 0.56% | 0.0% |
| Geode Capital Management, LLC | 26.41K | 0.48% | +6.4% |
| Vanguard Fiduciary Trust Co | 16.20K | 0.29% | 0.0% |
| Jane Street Group, LLC | 15.73K | 0.28% | -71.2% |
| Prospect Financial Services LLC | 13.79K | 0.25% | 0.0% |
| Morgan Stanley | 7.50K | 0.13% | +15.4% |
| Tower Research Capital LLC (TRC) | 2.74K | 0.05% | +166.2% |
| Wells Fargo & Company | 2.30K | 0.04% | 0.0% |
| Westside Investment Management, Inc. | 1.65K | 0.03% | 0.0% |
| Lanark Financial Inc | 1.50K | 0.03% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ACXP
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 31.10K | 0.56% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 21.37K | 0.38% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 2.98K | 0.05% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 1.00K | 0.02% |
Frequently asked questions
Who is the largest shareholder of Acurx Pharmaceuticals?
Vanguard Capital Management LLC is the largest institutional shareholder of ACXP, owning 0.56% of shares outstanding (31.10K shares) as of its latest 13F filing.
What percentage of Acurx Pharmaceuticals is owned by institutions?
Institutions own about 3.6% of ACXP shares and 3.7% of the public float.
How much of Acurx Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 2.31% of ACXP shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.